Ibrahim TM - Search Results

1

Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis.

Shaker ME, Zalata KR, Mehal WZ, Shiha GE, Ibrahim TM. Shaker ME, et al. Among authors: ibrahim tm. Toxicol Appl Pharmacol. 2011 Apr 15;252(2):165-75. doi: 10.1016/j.taap.2011.02.004. Epub 2011 Feb 24. Toxicol Appl Pharmacol. 2011. PMID: 21316382 Free PMC article.

2

Comparison of vitamin E, L-carnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress.

Shaker ME, Houssen ME, Abo-Hashem EM, Ibrahim TM. Shaker ME, et al. Among authors: ibrahim tm. J Physiol Biochem. 2009 Sep;65(3):225-33. doi: 10.1007/BF03180575. J Physiol Biochem. 2009. PMID: 20119817

3

Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression.

Shaker ME, Salem HA, Shiha GE, Ibrahim TM. Shaker ME, et al. Among authors: ibrahim tm. Fundam Clin Pharmacol. 2011 Apr;25(2):248-57. doi: 10.1111/j.1472-8206.2010.00824.x. Fundam Clin Pharmacol. 2011. PMID: 20408881

4

Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis.

Shaker ME, Shiha GE, Ibrahim TM. Shaker ME, et al. Among authors: ibrahim tm. Eur J Pharmacol. 2011 Nov 30;670(2-3):593-600. doi: 10.1016/j.ejphar.2011.08.041. Epub 2011 Sep 8. Eur J Pharmacol. 2011. PMID: 21925495

5

Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases.

Shaker ME, Ghani A, Shiha GE, Ibrahim TM, Mehal WZ. Shaker ME, et al. Among authors: ibrahim tm. Biochim Biophys Acta. 2013 Aug;1833(8):1992-2003. doi: 10.1016/j.bbamcr.2013.02.033. Epub 2013 Mar 13. Biochim Biophys Acta. 2013. PMID: 23499874 Free PMC article.

6

Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.

Shaaban AA, Shaker ME, Zalata KR, El-kashef HA, Ibrahim TM. Shaaban AA, et al. Among authors: ibrahim tm. Chem Biol Interact. 2014 Jan 25;207:81-91. doi: 10.1016/j.cbi.2013.10.008. Epub 2013 Oct 18. Chem Biol Interact. 2014. PMID: 24144775

7

The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms.

Hazem SH, Shaker ME, Ashamallah SA, Ibrahim TM. Hazem SH, et al. Among authors: ibrahim tm. Chem Biol Interact. 2014 Sep 5;220:116-27. doi: 10.1016/j.cbi.2014.06.017. Epub 2014 Jun 25. Chem Biol Interact. 2014. PMID: 24973641

8

Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.

Shiha GE, Abu-Elsaad NM, Zalata KR, Ibrahim TM. Shiha GE, et al. Among authors: ibrahim tm. Clin Exp Pharmacol Physiol. 2014 Oct;41(10):788-97. doi: 10.1111/1440-1681.12286. Clin Exp Pharmacol Physiol. 2014. PMID: 25115651

9

The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis.

Elshal M, Abu-Elsaad N, El-Karef A, Ibrahim TM. Elshal M, et al. Among authors: ibrahim tm. Naunyn Schmiedebergs Arch Pharmacol. 2015 Dec;388(12):1293-304. doi: 10.1007/s00210-015-1157-7. Epub 2015 Aug 14. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 26269412

10

The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice.

Abu-Elsaad NM, Serrya MS, El-Karef AM, Ibrahim TM. Abu-Elsaad NM, et al. Among authors: ibrahim tm. Pharmacol Rep. 2016 Apr;68(2):275-82. doi: 10.1016/j.pharep.2015.08.015. Epub 2015 Sep 11. Pharmacol Rep. 2016. PMID: 26922527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters